Skip to main content
Log in

Localization of parathyroid enlargement: experience with technetium-99m methoxyisobutylisonitrile and thallium-201 scintigraphy, ultrasonography and computed tomography

  • Original Article
  • Published:
European Journal of Nuclear Medicine Aims and scope Submit manuscript

    We’re sorry, something doesn't seem to be working properly.

    Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.

Abstract

Technetium-99m methoxyisobutylisonitrile (MIBI), like thallium-201, has recently been introduced as a myocardial perfusion agent and is now also showing very promising results in parathyroid scintigrapy. The results of 201Tl/99mTc-pertechnetate and 99mTc-MIBI/99mTc-pertechnetate subtraction scintigraphy, ultrasonography and computed tomography are presented in a series of 43 patients operated on for hyperparathyroidism. All four imaging modalities were confirmed to be reliable, scintigraphy being the most accurate. Sensitivities ranged from 81% to 95%, that of 99mTc-MIBI being the highest. Moreover this tracer, which has more favourable physical and also biochemical properties, yielded images of superior quality. This allowed localization of the lesion by visual inspection only in as many as 86% of the patients with positive 99mTc-MIBI/99mTc-pertechnetate subtraction scintigraphy. We believe that the higher sensitivity, superior image quality and lower cost of 99mTc-MIBI imaging will make 99mTc-MIBI the new radiopharmaceutical of choice for parathyroid scintigraphy (when one takes into account the stability of labelling with large activities it is possible to perform three or four cardiac studies together with one parathyroid scintigraphic examination using one lyophililzed vial).

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Ferlin G, Borsato N, Camerani M, Conte N, Zotti D. New perspectives in localizing enlarged parathyroids by thallium-technetium subtraction scan. J Nucl Med 1983;24: 438–441.

    Google Scholar 

  2. Basarab RM, Manni A, Harrison TS. Dual isotope subtraction parathyroid scintigraphy in the preoperative evaluation of suspected hyperparathyroidism. Clin Nucl Med 1985;10: 300–314.

    Google Scholar 

  3. Young AE, Gaunt JI, Croft DN, Collins REC, Wells CP, Coakley AJ. Localization of parathyroid adenomas by thallium-201 and technetium-99m subtraction scanning. Br Med J 1983;286:1384–1386.

    Google Scholar 

  4. MacFarlane SD, Hanelin LG, Taft DA, Ryan J Jr, Fredlund PN. Localilzation of abnormal parathyroid glands using thallium-201. AM J Surg 1984;148: 7–12.

    Google Scholar 

  5. Fogelman I, McKillop JH, Bessent RG, Boyle IT, Gray HW, Gunn I, Hutchison JSF. Successful localisation of parathyroid adenomata by thallium-201 and technetium-99m subtraction scintigraphy: description of an improved technique. Eur J Nucl Med 1984;9: 545–547.

    Google Scholar 

  6. McKillop JH, Bessent RG, Fogelman I. Technetium-thallium subtraction images for location of parathyroid adenomata. J Nucl Med 1984;25: 1268.

    Google Scholar 

  7. Okerlund MD, Sheldon K, Corpuz S, O'Connel W, Faulkner D, Clark O, Galante M. A new method with high sensitivity and specificity for localization of abnormal parathyroid glands. Ann Surg 1984;200:381–387.

    Google Scholar 

  8. Ferguson WR, Laird JD, Russel CFJ. Experience with technetium-thallium subtraction imaging of parathyroid lesions. J Nucl Med 1984;25: P19.

    Google Scholar 

  9. Percival RC, Blake GM, Urwin GH, Talbot CH, Williams JL, Kanis J. Assessment of thallium-pertechnetate subtraction scintigraphy in hyperparathyroidism. Br J Radiol 1985;58: 131–135.

    Google Scholar 

  10. Winzelberg GG, Hydovitz JD, O'Hara KR, Anderson KM, Turbiner E, Danowski TS, Lippe RD, Melada GA, Harrison AM. Prospective comparison of 201Tl/Tc-99m pertechnetate parathyroid subtraction scintigraphy and high resolution parathyroid ultrasonography in patients with suspected parathyroid adenomas. Radiology 1985;155: 231–235.

    Google Scholar 

  11. Ling M, Okerlund M, O'Connel W, Hattner RS, Faulkner D, Corpuz S, Porter C, Clark O, Galante M. Optimized dual-isotope localization of parathyroid tumors: comparison of unprocessed, color comparison and subtraction techniques. J Nucl Med 1986;27:962.

    Google Scholar 

  12. Picard D, D'Amour P, Carrier L, Chartrand R, Poisson RL. Localization of abnormal parathyroid gland(s) using Tl201/iodine-123 subtraction scintigraphy in patients with hyperparathyroidism. Clin Nucl Med 1987;12: 60–63.

    Google Scholar 

  13. Borsato N, Zanco P, Camerani N, Saitta B. Scintigraphy of the parathyroid glands with 201Tl: experience with 250 operated patients. Nucl Med 1989;28: 26–28.

    Google Scholar 

  14. Miller DL, Doppman JL, Shawker TH, Krudy AG, Norton JA, Vucich JJ, Morrish KA, Marx SJ, Spiegel AM, Aurbach GD. Localization of parathyroid adenomas in patients who have undergone surgery. Part I. Noninvasive imaging methods. Radiology 1987;162: 133–137.

    Google Scholar 

  15. Park CH, Intenzo C, Cohen HE. Dual-tracer imaging for localization of parathyroid lesions. Clin Nucl Med 1986;11: 237–241.

    Google Scholar 

  16. Blue PW, Crawford G, Dydek G. Parathyroid subtraction imaging — pitfalls in diagnosis. Clin Nucl Med 1989;14: 47–57.

    Google Scholar 

  17. Erwin WD, Groch MW, Ali A, Fordham EW. Image normalization and background subtraction in 201Tl/Tc-99m parathyroid subtraction scintigraphy: effect on lesion detection. Clin Nucl Med 1992;17: 81–89.

    Google Scholar 

  18. Goris ML, Basso VL, Keeling C. Parathyroid imaging. J Nucl Med 1991;32:887–889.

    Google Scholar 

  19. Beierwaltes WH. Endocrine images: parathyroid adrenal cortex and medulla and other endocrine tumors. Part 2. J Nucl Med 1991;32: 1627–1639.

    Google Scholar 

  20. Fine JE. Parathyroid imaging: its current status and future role. Semin Nucl Med 1987;17: 350–359.

    Google Scholar 

  21. Basarab RM. The evolving role of parathyroid scintigraphy. Clin Nucl Med 1989;14: 58–60.

    Google Scholar 

  22. Coakley AJ. Parathyroid localization — how and when? Eur J Nucl Med 1991;18: 151–152.

    Google Scholar 

  23. Potchen EJ. Parathyroid imaging — current status and future prospects. J Nucl Med 1992;10: 1807–1809.

    Google Scholar 

  24. Wackers FJ, Berman DJ, Maddahi J, Watson DD, Beller GA, Strauss HW, Boucher CA, Picard M, Holman BL, Fridrich R, Inglese E, Delaloye B, Bischof-Delaloye A, Camin L, McKusik K. Technetium-99m-hexakis-2-methoxyisobutyl isonitrile: human biodistribution, dosimetry, safety and preliminary comparison to thallium-201 for myocardinal perfusion imaging. J Nucl Med 1989;30: 301–311.

    Google Scholar 

  25. Piwnica-Worms D, Holman BL. Noncardiac applications of hexakis-(alkylisonitrile) technetium-99m complexes. J Nucl Med 1990;7: 1166–1167.

    Google Scholar 

  26. Iskandrian A, Heo J, Kong B, Lyons E, Marsch S. Use of technetium-99m-isonitrile (RP-30A) in assessing left ventricular perfusion and funtion at rest and during exercise in coronary artery disease and comparison with coronary arteriography and exercise thallium-201 SPECT images. Am J Cardiol 1989;64: 270–275.

    Google Scholar 

  27. Kiat H, Maddahi J, Roy L, Van Train K, Friedman J, Berman DS. Comparison of technetium-99m-methoxy-isobutylisonitrile and thallium-201 for evaluation of coronary artery disease by planar and tomographic methods. Am Heart J 1989;117:1–11.

    Google Scholar 

  28. Coakley AJ, Kettle AG, Wells CP, O'Doherty MJ, Collins REC. 99Tcm sestamibi — a new agent for parathyroid imaging. Nucl Med Comm 1989;10: 791–794.

    Google Scholar 

  29. O'Doherty MJ, Kettle AG, Wells P, Collins EC, Coakley AJ. Parathyroid imaging with technetium-99m-sestamibi: preoperative localization and tissue uptake studies. J Nucl Med 1992;33: 313–318.

    Google Scholar 

  30. Taillefer R, Boucher Y, Potvin C, Lambert R. Detection and localization of parathyroid adenomas in patients with hyperparathyroidism using a single radionuclide imaging procedure with technetium-99m Sestamibi (double-phase study). J Nucl Med 1992;33: 1801–1807.

    Google Scholar 

  31. Chia-Hung K, Wan-Yu L, Shyh-Jen W, Shin Hwa Y. Visualization of suppressed thyroid tissue by Tc-99m MIBI. Clin Nucl Med 1991;16: 812–814.

    Google Scholar 

  32. O'Driscoll CM, Baker F, Casey MJ, Duffy G.J. Localization of recurrent medullary thyroid carcinoma with technetium-99m-methoxyisobutylnitrile scintigraphy: a case report: J Nucl Med 1991;32: 2281–2283.

    Google Scholar 

  33. Stark DD, Moss AA, Gamsu G, et al. Magnetic resonance imaging of the neck. II. Pathologic findings. Radiology 1984;150: 455–461.

    Google Scholar 

  34. Peck. WW, Higgins CB, Fisher MR, et al. Hyperparathyroidism: comparison of MR imaging with radionuclide scanning. Radiology 1987;163: 415–420.

    Google Scholar 

  35. Aufferman W, Gooding GAV, Okerlund MD, et al. Diagnosis of recurrent hyperparathyroidism: comparison of MR imaging and other imaging techniques. AJR 1988;150: 1027–1033.

    Google Scholar 

  36. Krubsack AJ, Wilson SD, Lawson TL, et al. Prospective comparison of radionuclide, computed tomographic, sonographic and magnetic resonance localization of parathyroid tumors. Surgery 1989;106: 639–646.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Geatti, O., Shapiro, B., Orsolon, P.G. et al. Localization of parathyroid enlargement: experience with technetium-99m methoxyisobutylisonitrile and thallium-201 scintigraphy, ultrasonography and computed tomography. Eur J Nucl Med 21, 17–22 (1994). https://doi.org/10.1007/BF00182301

Download citation

  • Revised:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00182301

Key words

Navigation